Prevalence and Multidrug Resistance of WHO-Priority Bacterial Pathogens in a Romanian Intensive Care Unit
Authors:
- Alina Simona BereanuABAlina Simona Bereanu
- Bogdan Ioana VintilăBVBogdan Ioana Vintilă
- Lilioara-Alexandra Oprinca-MujaLOLilioara-Alexandra Oprinca-Muja
- Rareș BereanuRBRareș Bereanu
- Ioana Roxana CodruICIoana Roxana Codru
- Raluca Maria BădilăRBRaluca Maria Bădilă
- Sandra Ioana NeamțuSNSandra Ioana Neamțu
- Cosmin Ioan MohorCMCosmin Ioan Mohor
- Liiana Carmen ProdanLPLiiana Carmen Prodan
- Mihai SavaMihai Sava
Open Access
- 7 April 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (7) , 2799
Abstract
Background/Objectives: The rise in healthcare-associated infections caused by multidrug-resistant (MDR) bacteria in hospitals, particularly in intensive care units, has resulted in increased rates of morbidity and mortality, escalating costs, and has become a significant public health concern. In our Intensive Care Unit, we address healthcare-associated infections caused by multidrug-resistant bacteria, with a specific focus on those listed in the WHO 2024 List of Critically and Highly Prioritized Pathogens. Methods: Over the course of 1 year, from 1 January to 31 December 2024, we monitored the prevalence of healthcare-associated infections in the Intensive Care Unit of the Sibiu County Emergency Clinical Hospital, Romania, and the antibiotic susceptibility of the isolated bacteria. Results: The majority of infections were caused by pathogens in the ESKAPEE group. The most frequently isolated microorganism was Klebsiella pneumoniae (36.8%), followed by Acinetobacter baumannii (24.5%), classified as a critical priority by the WHO in 2024. Most positive samples for critical priority pathogens, including Klebsiella pneumoniae and Acinetobacter baumannii, as well as all MRSA strains (high priority), were obtained from tracheal aspirates collected from intubated and mechanically ventilated patients. A significant proportion of the isolated bacteria were multidrug-resistant, including extensively drug-resistant and pan-drug-resistant strains. Conclusions: The increase in antibiotic and antimicrobial resistance among hospital strains raises serious concerns about limited treatment options.Keywords
This publication has 112 references indexed in Scilit:
- Central venous catheter insertion site and infection prevention in 2024. Author’s replyIntensive Care Medicine, 2024
- Central venous catheter insertion site and infection prevention in 2024Intensive Care Medicine, 2024
- Central venous catheter-related infection: does insertion site still matter? A French multicentric cohort studyIntensive Care Medicine, 2024
- Investigating the effects of zinc oxide and titanium dioxide nanoparticles on the formation of biofilm and persister cells in Klebsiella pneumoniaeJournal of Basic Microbiology, 2023
- Continuous infusion of meropenem–vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearanceInfection, 2023
- Klebsiella pneumoniae survives on surfaces as a dry biofilmAmerican Journal of Infection Control, 2023
- Isolation of extensively drug resistant Acinetobacter baumannii from environmental surfaces inside intensive care unitsAmerican Journal of Infection Control, 2022
- A Review on Basic Biology of Bacterial Biofilm Infections and Their Treatments by Nanotechnology-Based ApproachesProceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2019
- Management of KPC-producing Klebsiella pneumoniae infectionsClinical Microbiology and Infection, 2018
- Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniaePhytotherapy Research, 2015